Role of echocardiography for the assessment of left ventricular dysfunction due to cancer treatments

The use of echocardiography for the assessment of patients undergoing potentially cardiotoxic cancer treatments and for follow-up of treated patients is increasing and has become a significant public health problem due to the need for repeated examinations over time. Despite the technological advances of echocardiography, there are still uncertainties about how best to use this technique to identify and guide the management of cardiotoxicity. The purpose of this article is to discuss the role of echocardiography in the study of ventricular dysfunction due to cancer treatments, with the aim to clarify the main echocardiographic information to be provided, the methods to apply and the strategies to implement to streamline as much as possible the use of echocardiography in the field of cardioncology